PortfoliosLab logo
OMEX vs. CYCC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OMEX and CYCC is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

OMEX vs. CYCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Odyssey Marine Exploration, Inc. (OMEX) and Cyclacel Pharmaceuticals, Inc. (CYCC). The values are adjusted to include any dividend payments, if applicable.

-100.00%-99.50%-99.00%-98.50%-98.00%-97.50%December2025FebruaryMarchAprilMay
-97.61%
-100.00%
OMEX
CYCC

Key characteristics

Sharpe Ratio

OMEX:

-0.23

CYCC:

-0.35

Sortino Ratio

OMEX:

2.11

CYCC:

0.27

Omega Ratio

OMEX:

1.36

CYCC:

1.03

Calmar Ratio

OMEX:

-0.64

CYCC:

-0.62

Martin Ratio

OMEX:

-0.88

CYCC:

-0.87

Ulcer Index

OMEX:

71.69%

CYCC:

71.15%

Daily Std Dev

OMEX:

279.16%

CYCC:

168.51%

Max Drawdown

OMEX:

-99.70%

CYCC:

-100.00%

Current Drawdown

OMEX:

-98.71%

CYCC:

-100.00%

Fundamentals

Market Cap

OMEX:

$42.28M

CYCC:

$63.06M

EPS

OMEX:

$0.07

CYCC:

-$2.09

PEG Ratio

OMEX:

0.00

CYCC:

0.00

PS Ratio

OMEX:

51.60

CYCC:

1.47K

PB Ratio

OMEX:

0.00

CYCC:

2.02

Total Revenue (TTM)

OMEX:

$565.61K

CYCC:

$14.00K

Gross Profit (TTM)

OMEX:

-$1.65M

CYCC:

$12.00K

EBITDA (TTM)

OMEX:

-$10.64M

CYCC:

-$7.70M

Returns By Period

In the year-to-date period, OMEX achieves a 79.17% return, which is significantly higher than CYCC's 37.13% return. Over the past 10 years, OMEX has outperformed CYCC with an annualized return of -16.63%, while CYCC has yielded a comparatively lower -58.35% annualized return.


OMEX

YTD

79.17%

1M

230.77%

6M

148.36%

1Y

-64.46%

5Y*

-21.71%

10Y*

-16.63%

CYCC

YTD

37.13%

1M

91.61%

6M

-20.57%

1Y

-80.54%

5Y*

-61.65%

10Y*

-58.35%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OMEX vs. CYCC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OMEX
The Risk-Adjusted Performance Rank of OMEX is 5353
Overall Rank
The Sharpe Ratio Rank of OMEX is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of OMEX is 8787
Sortino Ratio Rank
The Omega Ratio Rank of OMEX is 9292
Omega Ratio Rank
The Calmar Ratio Rank of OMEX is 1212
Calmar Ratio Rank
The Martin Ratio Rank of OMEX is 3232
Martin Ratio Rank

CYCC
The Risk-Adjusted Performance Rank of CYCC is 3333
Overall Rank
The Sharpe Ratio Rank of CYCC is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of CYCC is 4545
Sortino Ratio Rank
The Omega Ratio Rank of CYCC is 4343
Omega Ratio Rank
The Calmar Ratio Rank of CYCC is 1313
Calmar Ratio Rank
The Martin Ratio Rank of CYCC is 3232
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OMEX vs. CYCC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Odyssey Marine Exploration, Inc. (OMEX) and Cyclacel Pharmaceuticals, Inc. (CYCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for OMEX, currently valued at -0.23, compared to the broader market-2.00-1.000.001.002.003.00
OMEX: -0.23
CYCC: -0.35
The chart of Sortino ratio for OMEX, currently valued at 2.11, compared to the broader market-6.00-4.00-2.000.002.004.00
OMEX: 2.11
CYCC: 0.27
The chart of Omega ratio for OMEX, currently valued at 1.36, compared to the broader market0.501.001.502.00
OMEX: 1.36
CYCC: 1.03
The chart of Calmar ratio for OMEX, currently valued at -0.64, compared to the broader market0.001.002.003.004.005.00
OMEX: -0.64
CYCC: -0.62
The chart of Martin ratio for OMEX, currently valued at -0.88, compared to the broader market-10.000.0010.0020.00
OMEX: -0.88
CYCC: -0.87

The current OMEX Sharpe Ratio is -0.23, which is higher than the CYCC Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of OMEX and CYCC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.70-0.60-0.50-0.40-0.30-0.20December2025FebruaryMarchAprilMay
-0.23
-0.35
OMEX
CYCC

Dividends

OMEX vs. CYCC - Dividend Comparison

OMEX has not paid dividends to shareholders, while CYCC's dividend yield for the trailing twelve months is around 61.35%.


TTM202420232022202120202019201820172016
OMEX
Odyssey Marine Exploration, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CYCC
Cyclacel Pharmaceuticals, Inc.
61.35%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%

Drawdowns

OMEX vs. CYCC - Drawdown Comparison

The maximum OMEX drawdown since its inception was -99.70%, roughly equal to the maximum CYCC drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for OMEX and CYCC. For additional features, visit the drawdowns tool.


-100.00%-99.50%-99.00%-98.50%December2025FebruaryMarchAprilMay
-98.71%
-100.00%
OMEX
CYCC

Volatility

OMEX vs. CYCC - Volatility Comparison

Odyssey Marine Exploration, Inc. (OMEX) has a higher volatility of 113.26% compared to Cyclacel Pharmaceuticals, Inc. (CYCC) at 90.71%. This indicates that OMEX's price experiences larger fluctuations and is considered to be riskier than CYCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%120.00%December2025FebruaryMarchAprilMay
113.26%
90.71%
OMEX
CYCC

Financials

OMEX vs. CYCC - Financials Comparison

This section allows you to compare key financial metrics between Odyssey Marine Exploration, Inc. and Cyclacel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00K400.00K600.00K800.00K1.00M20212022202320242025
136.15K
0
(OMEX) Total Revenue
(CYCC) Total Revenue
Values in USD except per share items